Multidrug pain management package
AssigneeAlgia Pharma, LLC
InventorsDavid L. Steinberg, Joseph Loskove, Hannah Thompson
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a multidrug pain management package to dispense two or more medicaments to treat pain comprising a primary n-polygon, and one or more concentric m-polygons, wherein each side of the n-polygon and m-polygons have at least n or m-medicament chambers capable of holding the two or more medicaments. Also disclosed herein is a multidrug pain management package comprising a disk, wherein the disk is divided into equally spaced regions, and wherein each region has chambers capable of holding medicaments. Also disclosed herein are single formulations to treat pain.
Claims20
A single formulation consisting of:
- a. acetaminophen;
- b. one or more nonsteroidal anti-inflammatory drug;
- c. a gabapentinoid;
- and
- d. at least two additional active ingredients selected from the group consisting of:
- alpha 2 agonists, corticosteroids, H2 blockers, proton pump inhibitors, antacids, SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin Norepinephrine Reuptake Inhibitors), sleep aids drugs, natural sleep aids, magnesium, zinc, vitamin C, vitamin D, and tramadol.
A single formulation consisting of:
- a. acetaminophen;
- b. one or more nonsteroidal anti-inflammatory drug;
- c. a gabapentinoid;
- and
- d. at least two additional active ingredients selected from the group consisting of:
- alpha 2 agonists, corticosteroids, H2 blockers, proton pump inhibitors, antacids, SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin Norepinephrine Reuptake Inhibitors), sleep aids drugs, natural sleep aids, magnesium, and tramadol, zinc, vitamin C, vitamin D, and tramadol,
- and
- wherein the single formulation is given to a patient on the first day every eight hours.
A single formulation consisting of:
- a. acetaminophen;
- b. one or more nonsteroidal anti-inflammatory drug;
- c. a gabapentinoid;
- and
- d. at least two additional active ingredients selected from the group consisting of:
- alpha 2 agonists, corticosteroids, H2 blockers, proton pump inhibitors, antacids, SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin Norepinephrine Reuptake Inhibitors), sleep aids drugs, natural sleep aids, magnesium, zinc, vitamin C, vitamin D, and tramadol,
- and
- wherein the single formulation is dispensed by an inhaler to a patient.
A single formulation consisting of:
- a. acetaminophen;
- b. one or more nonsteroidal anti-inflammatory drug;
- c. a gabapentinoid;
- d. one or more corticosteroids;
- and
- e. one or more H2 blockers.
A single formulation consisting of:
- a. acetaminophen;
- b. one or more nonsteroidal anti-inflammatory drug;
- c. a gabapentinoid;
- and
- d. at least two additional active ingredients selected from the group consisting of:
- corticosteroids, H2 blockers, magnesium, zinc, vitamin C, and vitamin D.
Dependencies are inferred from the claim text.